The following information is disclosed in accordance with Rule 26 of the AIM rules for companies (Feb 2007). It was last updated on 18 August 2007

Company Overview

Personal Screening plc has two trading subsidiaries, Personal Screening International Limited and Mermaid Diagnostics Limited.

The self-test medical kits sold by Personal Screening International Limited are in a similar format to pregnancy kits. Personal Screening has identified a range of tests that are likely to appeal to groups which are at a substantial risk of contracting the relevant condition. The kits detect conditions where early diagnosis has a significant benefit to the user. Customers are supplied with all the items necessary to conduct a test at home, together with appropriate advisory and instructional material. In the event of a positive result, the user is urged to seek a medical opinion.
Traditionally it has been the role of the GP to make a primary diagnosis of a patient. Sometimes it is necessary for tests to be carried out by a pathology laboratory which are often situated in the local hospital. This process takes time. It involves repeated visits by the patient to the GP (and the laboratory) and there is a delay while the laboratory processes the test. More importantly the process usually begins after symptoms are apparent. Screening of at risk groups can result in earlier detection of illnesses.

The tests are either conducted on finger prick blood or urine samples.

Mermaid Diagnostics Limited was acquired in 2006. It holds patents over a device known as Safetube®. This is a patented technology which allows quick and easy-to-use colorimetric and other assays to be carried out away from the laboratory without the need for expensive instrumentation. The device allows reactive chemicals to be isolated from one another before the test and safely contains reagents and sample after use, reducing the chance of operator contamination and allowing for safe disposal.

SmokeScreen® is the first commercialised use of SafeTube®. It is a 6-minute urine test can be used on its own to correctly identify smokers, with a colour chart for a semi-quantitative measure of smoking and urine can be analysed with the new dedicated colorimeter for a quantitative measure of nicotine intake. This instrument is sensitive enough to detect down to passive smoking levels. The colorimetric assay used turns a urine sample different shades of pink.

Personal Screening and its subsidiaries are registered in England and Great Britain is the main country of operation.

Directors

The Board is responsible for creating value for shareholders, determining strategy, investment and acquisition policy, approving significant items of expenditure and consideration of significant financing and legal matters.

The Group is currently led and controlled by a Board consisting of two Executive Directors and 1 Non-executive Director. The Board considers that the Non-execuitve Director is independant and has specific expertise and experience, materially enhancing knowledge, judgement and overall performance of the Board.


Michael George Scorey, Non Executive Chairman

Michael is responsible for group strategy and planning. Michael chairs the remuneration and audit committees.

Michael began his career with Shearson Lehman stockbrokers. Between 1973 and 1994 he was an executive director of various investment management businesses and was a non executive director of several UK quoted companies. In 1993 he became Deputy Chairman of Omnicare Plc, a home healthcare and medical oxygen services business which was floated on AIM in 1995 and subsequently acquired by Allied Healthcare Group Limited, a major US owned healthcare services provider, in 1997. He was UK Chairman of Allied Healthcare Group Limited until 1998 when he became Chairman of Clinovia Holdings Limited, the UK’s leading supplier of high-tech home healthcare treatments. After five years of rapid growth Clinovia Holdings Limited was eventually acquired by a major UK private equity group in 2003 for approximately £45 million. Michael is currently also Chairman of Onstream Limited which is a long-established offshore oil services business. He holds a first class honours degree from London School of Economics.

Simon Peter Driscoll, MBA, Managing Director

Simon is responsible for the day-to-day operation and development of the group.

Simon was part time Managing Director of Personal Screening until January 2005 when he stepped down as Chief Executive Officer of Galleon Holdings plc to dedicate all of his time to Personal Screening. Previously he was employed as a business strategist at Sanctuary Group plc and The British Oxygen Company Limited. He held marketing and technical roles at Linde (UK) Limited and Low & Bonar plc. Simon’s vocational training also includes the executive management programme of the Munich-based Linde AG. He holds a BSc degree from Brunel University and an MBA from Birmingham University.

Aniz Visram, B.Sc (Hon); F.C.A., Finance Director

Aniz has responsibility for all financial and company accounting matters together with corporate finance matters.

Aniz Visram trained and qualified in 1982 as an accountant with Deloitte Touche (formerly Touche Ross & Co). In 1985 he joined a Birmingham based accountancy practice, Kenneth Hayes & Co, where he specialised in audit and accountancy services for small to medium sized businesses. In 1993 he set up his own practice in the name of Aniz Visram & Co and has been actively involved in that practice. More recently the practice has specialised in servicing the medical profession.

Advisors
NOMAD Nabarro Wells
Saddlers House
Gutter Lane
London
EC2V 6BR

Broker SP Angel
East India House
109 – 117 Middlesex Street
London
E1 7JF

Auditors Bentley Jennison
Charterhouse
Legge Street
Birmingham
B4 7EU

Please view our statements and accounts below.If you require further information pelase contact us.

Number of shares in issue

178,633,198 ordinary shares of 0.1p each change the number to 290,538,245

Substantial shareholders

There are 129,140,162 shares (44%) not in public hands.
There are no restrictions on the transfer of the company's AIM securities.
Personal Screening plc is only listed on AIM, part of the London Stock Exchange

Company Documents

Announcements

Press Articles